Biogen Pharma

  • Market Cap: Micro Cap
  • Industry: Non Banking Financial Company (NBFC)
  • ISIN: INE703D01023
  • NSEID:
  • BSEID: 531752
INR
0.69
0.00 (0.00%)
BSENSE

Feb 09

BSE+NSE Vol: 13.77 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 200854,
    "name": "Biogen Pharma",
    "stock_name": "Biogen Pharma",
    "full_name": "Biogen Pharmachem Industries Ltd",
    "name_url": "stocks-analysis/biogen-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "0.69",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "0.69",
    "mcapval": "62.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531752,
    "symbol": "",
    "ind_name": "Non Banking Financial Company (NBFC)",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE703D01023",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "13.77 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biogen-pharma-200854-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Biogen Pharmachem Industries Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-biogen-pharmachem-industries-ltd-3821230",
        "imagepath": "",
        "date": "2026-02-04 23:17:08",
        "description": "The next results date for Biogen Pharmachem Industries Ltd is scheduled for 11 February 2026...."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-3811133",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BiogenPharmache_mojoScore_3811133.png",
        "date": "2026-01-30 10:10:35",
        "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 08 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs.0.63",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs063-3798390",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BiogenPharmache_priceRelatedfactors_3798390.png",
        "date": "2026-01-21 10:51:04",
        "description": "Biogen Pharmachem Industries Ltd has touched a new 52-week low of Rs.0.63 today, marking a significant decline in its stock price amid broader market pressures and company-specific factors. This fresh low reflects ongoing challenges faced by the company within the Non Banking Financial Company (NBFC) sector, as it continues to trade below all key moving averages and underperforms its sector peers."
      },
      {
        "title": "When is the next results date for Biogen Pharmachem Industries Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-biogen-pharmachem-industries-ltd-3797093",
        "imagepath": "",
        "date": "2026-01-20 23:16:13",
        "description": "The next results date for Biogen Pharmachem Industries Ltd is scheduled for February 3, 2026...."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs.0.64",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs064-3796802",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BiogenPharmache_priceRelatedfactors_3796802.png",
        "date": "2026-01-20 15:41:44",
        "description": "Biogen Pharmachem Industries Ltd has reached a new 52-week low of Rs.0.64, marking a significant decline in its stock price amid broader market fluctuations and sectoral pressures. This latest low reflects ongoing concerns about the company’s financial health and valuation metrics within the Non Banking Financial Company (NBFC) sector."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs.0.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs065-3794438",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BiogenPharmache_priceRelatedfactors_3794438.png",
        "date": "2026-01-19 10:30:33",
        "description": "Biogen Pharmachem Industries Ltd has touched a new 52-week low of Rs.0.65 today, marking a significant decline in its share price amid broader market pressures and company-specific financial concerns."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-3794074",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BiogenPharmache_mojoScore_3794074.png",
        "date": "2026-01-19 10:10:18",
        "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a reassessment of the company’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 19 January 2026, providing investors with the latest view of the stock’s position in the market."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-3784464",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BiogenPharmache_mojoScore_3784464.png",
        "date": "2026-01-07 10:10:23",
        "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 07 January 2026, providing investors with the most up-to-date view of its fundamentals, valuation, financial trend, and technical standing."
      },
      {
        "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs.0.68",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs068-3776458",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/BiogenPharmache_priceRelatedfactors_3776458.png",
        "date": "2025-12-31 12:15:11",
        "description": "Biogen Pharmachem Industries Ltd has declined to a fresh 52-week low of Rs.0.68, marking a significant drop in its share price amid a broader market environment where the Sensex continues to show strength. This new low reflects ongoing pressures on the stock, which has underperformed its sector and the broader market over the past year."
      }
    ],
    "total": 69,
    "sid": "200854",
    "stock_news_url": "https://www.marketsmojo.com/news/biogen-pharmachem-industries-200854"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Reschedule Board Meeting As Per Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting.",
      "datetime": "03-Feb-2026",
      "details": "Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Pursuant to regulation 29(1)(d) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the meeting of Board of Director of the Company which is going to be held today 3rd February 2026 stands postponed due to unavoidable circumstances and rescheduled on Wednesday 11th February 2026. inter alia to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter and nine months ended as on 31st December 2025. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You",
      "source": "BSE"
    },
    {
      "caption": "Updation Of Website Of The Company.",
      "datetime": "03-Feb-2026",
      "details": "PFA",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting.",
      "datetime": "19-Jan-2026",
      "details": "Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 3rd February 2026 inter alia to consider following businesses: - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter and nine months ended as on 31st December 2025. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "11 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for Reschedule Board Meeting As Per Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting.

03-Feb-2026 | Source : BSE

Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 inter alia to consider and approve Pursuant to regulation 29(1)(d) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 we wish to inform you that the meeting of Board of Director of the Company which is going to be held today 3rd February 2026 stands postponed due to unavoidable circumstances and rescheduled on Wednesday 11th February 2026. inter alia to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter and nine months ended as on 31st December 2025. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You

Updation Of Website Of The Company.

03-Feb-2026 | Source : BSE

PFA

Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting.

19-Jan-2026 | Source : BSE

Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday 3rd February 2026 inter alia to consider following businesses: - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter and nine months ended as on 31st December 2025. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

11 Feb 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available